Download PDF
Aktuelle Ernährungsmedizin 2003; 28: 61-68
DOI: 10.1055/s-2003-36939
Onkologie
© Georg Thieme Verlag Stuttgart · New York

DGEM-Leitlinie Enterale Ernährung:
Onkologie

DGEM Guidelines Enteral Nutrition: OncologyJ.  Arends1 , G.  Zürcher2 , R.  Fietkau3 , E.  Aulbert4 , B.  Frick5 , M.  Holm6 , M.  Kneba7 , H.  J.  Mestrom8 , A.  Zander9
  • 1Klinik für Tumorbiologie an der Albert-Ludwigs Universität Freiburg
  • 2Innere Medizin I - Hämatologie, Onkologie, Med. Universitätsklinik und Poliklinik, Freiburg
  • 3Klinik und Poliklinik für Strahlentherapie, Universität Rostock
  • 4Innere Abt. Ev. Waldkrankenhaus Spandau
  • 5Apotheke des Universitätsklinikums Freiburg
  • 6II. Med. Klinik, Univ.-Klinikum Mannheim
  • 7II. Med. Klinik, Universität Kiel
  • 8Klinik Bergisch-Land, Wuppertal
  • 9Einrichtung für Knochenmarktransplantation, Universitätsklinik Hamburg-Eppendorf
Further Information

Publication History

Publication Date:
27 January 2003 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Sondenernährung - Onkologie - Mangelernährung - Kachexie - Komplikationen

Key words

Enteral nutrition - oncology - malnutrition - cachexia - complications

Literatur

  • 1 Pichard C, Kyle U G. Body composition measurements during wasting diseases.  Clin Nutr Metab Care. 1998;  1 357-361
    PubMedGoogle Scholar
  • 2 ASPEN Board of Directors, Clinical Guidelines Task Force . Specific guidelines for disease - adults: cancer.  JPEN. 2002;  26 82SA-83SA
    PubMedGoogle Scholar
  • 3 Blackburn G L, Bistrian B R, Maini B R, Schlamm H T, Smith M F. Nutritional and metabolic assessment of the hospitalized patient.  JPEN. 1977;  1 11-22
    PubMedGoogle Scholar
  • 4 Detsky A S, McLaughlin J R, Baker J P. et al . What is Subjective Global Assessment of Nutritional Status?.  JPEN. 1987;  11 8-13
    CrossrefPubMedGoogle Scholar
  • 5 Dwyer J T. Dietary Assessment. In: Shils ME, Olson JA, Shike M (eds) Modern nutrition in health and disease. Philadelphia; Lea & Febiger 1994: 842-860
    Google Scholar
  • 6 Hackl J M, Balogh D. Indikation zur künstlichen Ernährung - was ist gesichert?.  Akt Ernährungsmed. 1997;  22 146-153
    PubMedGoogle Scholar
  • 7 Arbeitsgemeinschaft für Klinische Ernährung .Empfehlungen für die parenterale und enterale Ernährungstherapie des Erwachsenen. 2000
    Google Scholar
  • 8 Ollenschläger G, Konkol K, Mödder B. Indications for and results of nutritional therapy in cancer patients.  Recent Results Cancer Res. 1988;  108 172-184
    PubMedGoogle Scholar
  • 9 van Hoof P, Buill-Haasen M, Rouflart N, Soeters P B, von Meyenfeldt M F. Anorexia, malnutrition and food aversion with newly detected gastric or colorectal cancer.  Clin Nutr. 1989;  8 151
    PubMedGoogle Scholar
  • 10 DGE, ÖGE, SGE, SVE .Referenzwerte für die Nährstoffzufuhr. Frankfurt am Main; Umschau Braus 2000
    Google Scholar
  • 11 DeWys W D, Begg C, Lavin P T. et al . Prognostic effect of weight loss prior to chemotherapy in cancer patients.  Am J Med. 1980;  69 491-497
    PubMedGoogle Scholar
  • 12 Chute C G, Greenberg E R, Baron J, Korson R, Baker J, Yates J. Presenting conditions of 1539 population-based lung cancer patients by cell type and stage in New Hampshire and Vermont.  Cancer. 1985;  56 2107-2111
    PubMedGoogle Scholar
  • 13 Wigmore S J, Plester C E, Richardson R A, Fearon K CH. Changes in nutritional status associated with unresectable pancreatic cancer.  Br J Cancer. 1997;  75 106-109
    PubMedGoogle Scholar
  • 14 Andreyev H JN, Norman A R, Oates J, Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?.  Eur J Cancer. 1998;  34 503-509
    CrossrefPubMedGoogle Scholar
  • 15 Costa G, Donaldson S S. Current concepts in cancer.  N Engl J Med. 1979;  300 1471-1473
    PubMedGoogle Scholar
  • 16 McAnena O J, Daly J M. Impact of antitumor therapy on nutrition.  Surg Clin North Am. 1986;  66 1213-1228
    PubMedGoogle Scholar
  • 17 Knox L S, Crosby L O, Feurer I D, Buzby G P, Miller C L, Mullen J L. Energy expenditure in malnourished cancer patients.  Ann Surg. 1983;  197 152-161
    CrossrefPubMedGoogle Scholar
  • 18 Dempsey D T, Feurer I D, Knox L S, Crosby L O, Buzby G P, Mullen J L. Energy expenditure in malnourished gastrointestinal cancer patients.  Cancer. 1984;  53 1265-1273
    CrossrefPubMedGoogle Scholar
  • 19 Dempsey D T, Knox L S, Mullen J L, Miller C L, Feurer I D, Buzby G P. Energy expenditure in malnourished patients with colorectal cancer.  Arch Surg. 1986;  121 789-795
    CrossrefPubMedGoogle Scholar
  • 20 Moldawer L L, Copeland E M. Proinflammatory cytokines, nutritional support, and the cachexia syndrom.  Cancer. 1997;  79 1828-1839
    CrossrefPubMedGoogle Scholar
  • 21 de Blaauw I, Deutz N EP, von Meyenfeldt M F. Metabolic changes in cancer cachexia - first of two parts.  Clin Nutr. 1997;  16 169-176
    PubMedGoogle Scholar
  • 22 de Blaauw I, Deutz N EP, von Meyenfeldt M F. Metabolic changes of cancer cachexia - second of two parts.  Clin Nutr. 1997;  16 223-228
    PubMedGoogle Scholar
  • 23 Inui A. Cancer anorexia-cachexia syndrome: Are neuropeptides the key?.  Cancer Res. 1999;  59 4493-4501
    PubMedGoogle Scholar
  • 24 von Meyenfeldt M F. Nutritional support during treatment of biliopancreatic malignancy.  Ann Oncol. 1999;  10 273-277
    CrossrefPubMedGoogle Scholar
  • 25 Fearon K CH, Barber M D, Falconer J S, McMillan D C, Ross J A, Preston T. Pancreatic cancer as a model: Inflammatory mediators, acute-phase response, and cancer cachexia.  World J Surg. 1999;  23 584-588
    PubMedGoogle Scholar
  • 26 Fordy C, Glover C, Henderson D C, Summerbell C, Wharton R, Allen-Mersh T G. Contribution of diet, tumour volume and patient-related factors to weight loss in patients with colorectal liver metastases.  Br J Surg. 1999;  86 639-644
    CrossrefPubMedGoogle Scholar
  • 27 Simons J PFHA, Schols A M, Buurman W A, Wouters E F. Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones.  Clin Sci. 1999;  97 215-223
    PubMedGoogle Scholar
  • 28 Espat N J, Moldawer L L, Copeland E M. Cytokine-mediated alterations in host metabolism prevent nutritional repletion in cachectic cancer patients.  J Surg Oncol. 1995;  58 77-82
    PubMedGoogle Scholar
  • 29 Martin F, Santolaria F, Batista N. et al . Cytokine levels (IL-6 and IFN-gamma), acute phase response and nutritional status as prognostic factors in lung cancer.  Cytokine. 1999;  11 80-86
    CrossrefPubMedGoogle Scholar
  • 30 O'Gorman P, McMillan D C, McArdle C S. Prognostic factors in advanced gastrointestinal cancer patients with weight loss.  Nutr Cancer. 2000;  37 36-40
    PubMedGoogle Scholar
  • 31 Lundholm K, Holm G, Schersten T. Insulin resistance in patients with cancer.  Cancer Res. 1978;  38 4665-4670
    PubMedGoogle Scholar
  • 32 Starnes H F, Warren R S, Brennan M F. Protein synthesis in hepatocytes isolated from patients with gastrointestinal malignancy.  J Clin Invest. 1987;  80 1384-1390
    PubMedGoogle Scholar
  • 33 Shaw J HF, Wolfe R R. Fatty acid and glycerol kinetics in septic patients and in patients with gastrointestinal cancer.  Ann Surg. 1997;  205 368-376
    PubMedGoogle Scholar
  • 34 Zuijdgeest-van Leeuwen S D, van den Berg J WO, Wattimena J LD. et al . Lipolysis and lipid oxidation in weight-losing cancer patients and healthy subjects.  Metabolism. 2000;  49 931-936
    CrossrefPubMedGoogle Scholar
  • 35 Körber J, Pricelius S, Heidrich M, Müller M J. Increased lipid utilization in weight losing and weight stable cancer patients with normal body weight.  Eur J Clin Nutr. 1999;  53 740-745
    CrossrefPubMedGoogle Scholar
  • 36 Barber M D, McMillan D C, Preston T, Ross J A, Fearon K CH. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement.  Clin Sci. 2000;  98 389-399
    PubMedGoogle Scholar
  • 37 Legaspi A, Jeevanandam M, Starnes H F, Brennan M F. Whole body lipid and energy metabolism in the cancer patient.  Metabolism. 1987;  36 958-963
    CrossrefPubMedGoogle Scholar
  • 38 Jeevanandam M, Horowitz G D, Lowry S F, Brennan M F. Cancer cachexia and protein metabolism.  Lancet. 1984;  1 1424-1426
    PubMedGoogle Scholar
  • 39 Williams A, Sun X, Fischer J F, Hasselgren P O. The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer.  Surgery. 1999;  126 744-750
    CrossrefPubMedGoogle Scholar
  • 40 Bossola M, Muscaritoli M, Costelli P. et al . Increased muscle ubiquitin mRNA levels in gastric cancer patients.  Am J Physiol Regulatory Integrative Comp Physiol. 2001;  280 R1518-R1523
    PubMedGoogle Scholar
  • 41 Tisdale M J. Protein loss in cancer cachexia.  Science. 2000;  289 2293-2294
    CrossrefPubMedGoogle Scholar
  • 42 Cabal-Manzano R, Bhargava P, Torres-Duarte A, Marshall J, Bhargava P, Wainer I W. Proteolysis-inducing factor is expressed in tumours of patients with gastrointestinal cancers and correlates with weight loss.  Br J Cancer. 2001;  84 1599-1601
    CrossrefPubMedGoogle Scholar
  • 43 Tubiana M, Attié E, Flamant R, Gérard-Marchant R, Hayat M. Prognostic factors in 454 cases of Hodgkin's Disease.  Cancer Res. 1971;  31 1801-1810
    PubMedGoogle Scholar
  • 44 Swenerton K D, Legha S S, Smith T. et al . Prognostic factors in metastatic breast cancer treated with combination chemotherapy.  Cancer Res. 1979;  39 1552-1562
    PubMedGoogle Scholar
  • 45 van Eys J. Effect of nutritional status on response to therapy.  Cancer Res. 1982;  42 747-753
    PubMedGoogle Scholar
  • 46 Pedersen H, Hansen H S, Cederqvist C, Lober J. The prognostic significance of weight loss and its integration in stage-grouping of oesophageal cancer.  Acta Chir Scand. 1982;  148 363-366
    PubMedGoogle Scholar
  • 47 Fein R, Kelsen D P, Geller N, Bains M, McCormack P, Brennan M F. Adenocarcinoma of the esophagus and gastroesophageal junction.  Cancer. 1985;  56 2512-2518
    CrossrefPubMedGoogle Scholar
  • 48 Coates R J, Clark W S, Eley J W, Greenberg R S, Huguley C M, Brown R L. Race, nutritional status and survival from breast cancer.  J Natl Cancer Inst. 1990;  82 1684-1692
    PubMedGoogle Scholar
  • 49 van Bokhorst-de van der Schueren M AE, van Leeuwen P AM, Kuik D J. et al . The impact of nutritional status on the prognoses of patients with advanced head and neck cancer.  Cancer. 1999;  86 519-527
    CrossrefPubMedGoogle Scholar
  • 50 Ollenschläger G, Thomas W, Konkol K, Diehl V, Roth E. Nutritional behaviour and quality of life during oncological polychemotherapy: results of a prospective study on the efficacy of oral nutrition therapy in patients with acute leukaemia.  Eur J Clin Invest. 1992;  22 546-553
    PubMedGoogle Scholar
  • 51 Bruning P F, Egger R J, Gooskens A C. et al . Dietary intake, nutritional status and well-being of cancer patients: a prospective study.  Eur J Cancer. 1985;  21 1449-1459
    PubMedGoogle Scholar
  • 52 Padilla G V. Psychological aspects of nutrition and cancer.  Surg Clin North Am. 1986;  66 1121-1135
    PubMedGoogle Scholar
  • 53 Fietkau R. Principles of feeding cancer patients via enteral or parenteral nutrition during radiotherapy.  Strahlentherapie und Onkologie. 1998;  174 47-51
    PubMedGoogle Scholar
  • 54 Ovesen L, Allingstrup L, Hannibal E, Mortensen E L, Hansen P. Effect of dietary counseling on food intake body weight, response rate, survival and quality of life in cancer patients undergoing chemotherapy: a prospective randomized study.  J Clin Oncol. 1993;  11 2043-2049
    PubMedGoogle Scholar
  • 55 Edington J, Winter P D, Coles S J, Gale C R, Martyn C N. Outcomes of undernutrition in patients in the community with cancer or cardiovascular disease.  Proc Nutr Soc. 1999;  58 655-661
    CrossrefPubMedGoogle Scholar
  • 56 Warren S. The immediate causes of death in cancer.  Am J Med Sci. 1932;  184 610-615
    PubMedGoogle Scholar
  • 57 Aslani A, Smith R C, Allen B J, Paviakis N, Levi J A. The predictive value of body protein for chemotherapy-induced toxicity.  Cancer. 2000;  88 796-803
    CrossrefPubMedGoogle Scholar
  • 58 Anonymous . American Gastroenterological Association medical position statement: parenteral nutrition.  Gastroenterology. 2001;  121 966-969
    PubMedGoogle Scholar
  • 59 Sax H C, Souba W W. Enteral and parenteral feedings. Guidelines and recommendations.  Med Clin North Am. 1993;  77 863-880
    PubMedGoogle Scholar
  • 60 ASPEN Board of Directors, Clinical Guidelines Task Force . Indications for specialized nutrition support.  JPEN. 2002;  26 18SA-20SA
    PubMedGoogle Scholar
  • 61 Brennan M F, Ekman L. Metabolic consequences of nutritional support of the cancer patient.  Cancer. 1984;  54 2627-2634
    CrossrefPubMedGoogle Scholar
  • 62 Bodoky A, Dupont V, Heberer M, Harder F. Heimenterale Ernährung über Jejunostomiekatheter.  Helvetica Chirurgica Acta. 1990;  57 141-146
    PubMedGoogle Scholar
  • 63 Campos A C, Butters M, Meguid M M. Home enteral nutrition via gastrostomy in advanced head and neck cancer patients.  Head & Neck. 1990;  12 137-142
    PubMedGoogle Scholar
  • 64 Klein S, Koretz R L. Nutrition support in patients with cancer: What do the data really show?.  Nutr Clin Pract. 1994;  9 91-100
    CrossrefPubMedGoogle Scholar
  • 65 Mercadante S. Parenteral versus enteral nutrition in cancer patients: indications and practice.  Supp Care Cancer. 1998;  6 85-93
    PubMedGoogle Scholar
  • 66 Evans W K, Nixon D W, Daly J M. et al . A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small-cell lung cancer.  J Clin Oncol. 1987;  5 113-124
    PubMedGoogle Scholar
  • 67 Ovesen L, Allingstrup L. Different quantities of two commercial liquid diets consumed by weigh-losing cancer patients.  JPEN. 1992;  16 275-278
    PubMedGoogle Scholar
  • 68 Lee J H, Machtay M, Unger L D. et al . Prophylactic gastrostomy tubes in patients undergoing intensive irradiation for cancer of the head and neck.  Arch Otolaryngol Head Neck Surg. 1998;  124 871-875
    CrossrefPubMedGoogle Scholar
  • 69 Bozzetti F, Cozzaglio L, Gavazzi C. et al . Nutritional support in patients with cancer of the esophagus: impact on nutritional status, patient compliance to therapy, and survival.  Tumori. 1998;  84 681-686
    PubMedGoogle Scholar
  • 70 Fietkau R, Iro H, Sailer D, Sauer R. Percutaneous endoscopically guided gastrostomy in patients with head and neck cancer.  Recent Results Cancer Res. 1991;  121 269-282
    PubMedGoogle Scholar
  • 71 Ottery F D, Walsh D, Strawford A. Pharmacologic management of anorexia/cachexia.  Sem Oncol. 1998;  25 35-44
    PubMedGoogle Scholar
  • 72 Strang P. The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS patients (Review).  Anticaner Res. 1997;  17 657-662
    PubMedGoogle Scholar
  • 73 McMillan D C, O'Gorman P, Fearon K CH, McArdle C S. A pilot study of megestrol acetate and ibuprofen in the treatment of cachexia in gastrointestinal cancer patients.  Br J Cancer. 1997;  76 788-790
    PubMedGoogle Scholar
  • 74 Simons J PFHA, Schols A M, Hoefnagels J MJ, Westerterp K R, tenVelde G PM, Wouters E F. Effects of medroxyprogesterone acetate on food intake, body composition, and resting energy expenditure in patients with advanced, nonhormone-sensitive cancer.  Cancer. 1998;  82 553-560
    CrossrefPubMedGoogle Scholar
  • 75 Fietkau R, Riepl M, Kettner H, Hinke A, Sauer R. Supportive Behandlung mit Megestrolacetat während der Radio-(Chemo-)Therapie bei Patienten mit Tumoren im Kopf-Hals-Bereich.  Strahlentherapie und Onkologie. 1996;  172 162-168
    PubMedGoogle Scholar
  • 76 Bruera E, Macmillan K, Kuehn N, Hanson J, MacDonald R N. A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer.  Cancer. 1990;  66 1279-1282
    PubMedGoogle Scholar
  • 77 McMillan D C, Simpson J M, Preston T. et al . Effect of megestrol acetate on weight loss, body composition and blood screen of gastrointestinal cancer patients.  Clin Nutr. 1994;  13 85-89
    PubMedGoogle Scholar
  • 78 Maltoni M, Nanni O, Scarpi E, Rossi D, Serra P, Amadori D. High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials.  Ann Oncol. 2001;  12 289-300
    CrossrefPubMedGoogle Scholar
  • 79 Loprinzi C L, Kugler J W, Sloan J A. et al . Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia.  J Clin Oncol. 1999;  17 3299-3306
    PubMedGoogle Scholar
  • 80 Wigmore S J, Ross J A, Falconer J S. et al . The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer.  Nutrition. 1996;  12 27-30
    PubMedGoogle Scholar
  • 81 Barber M D, Ross J A, Voss A C, Tisdale M J, Fearon K CH. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer.  Br J Cancer. 1999;  81 80-86
    PubMedGoogle Scholar
  • 82 Wigmore S J, Barber M D, Ross J A, Tisdale M J, Fearon K CH. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.  Nutr Cancer. 2000;  36 177-184
    CrossrefPubMedGoogle Scholar
  • 83 Gogos C A, Ginopoulos P, Salsa B, Apostolidou E, Zoumbos N C, Kalfarentzos F. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy.  Cancer. 1998;  82 395-402
    CrossrefPubMedGoogle Scholar
  • 84 Gianotti L, Braga M, Nespoli L, Radaelli G, Beneduce A, DiCarlo V. A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer.  Gastroenterology. 2002;  122 1763-1770
    CrossrefPubMedGoogle Scholar
  • 85 van Bokhorst-de van de Schueren M AE, Quak J J, von Blomberg-van der Flier M E. et al . Effect of perioperative nutrition, with and without arginine supplementation, on nutritional status, immune function, postoperative morbidity, and survival in severely malnourished head and neck cancer patients.  Am J Clin Nutr. 2001;  73 323-332
    PubMedGoogle Scholar
  • 86 Daly J M, Weintraub F N, Shou J, Rosato E F, Lucia M. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients.  Ann Surg. 1995;  221 327-338
    CrossrefPubMedGoogle Scholar
  • 87 Thiel H J, Fietkau R, Sauer R. Malnutrition and the role of nutritional support for radiation therapy patients.  Recent Results Cancer Res. 1988;  108 205-226
    PubMedGoogle Scholar
  • 88 Collins M M, Wight R G, Partridge G. Nutritional consequences of radiotherapy in early laryngeal carcinoma.  Ann Royal Coll Surg. 1999;  81 376-381
    PubMedGoogle Scholar
  • 89 Arnold C, Richter M P. The effect of oral nutritional supplements on head and neck cancer.  Int J Radiat Oncol Biol Phys. 1989;  16 1595-1599
    PubMedGoogle Scholar
  • 90 Nayel H, el-Ghoneimy E, el-Haddad S. Impact of nutritional supplementation on treatment delay and morbidity in patients with head and neck tumours treated with irradiation.  Nutrition. 1992;  8 13-18
    PubMedGoogle Scholar
  • 91 Marcy P Y, Magné N, Bensadoun R J. et al . Systematic percutaneous fluoroscopic gastrostomy for concomitant radiochemotherapy of advanced head and neck cancer: optimization of therapy.  Supp Care Cancer. 2000;  8 410-413
    PubMedGoogle Scholar
  • 92 Tyldesley S, Sheehan F, Munk P. et al . The use of radiologically placed gastrostomy tubes in head and neck cancer patients receiving radiotherapy.  Int J Radiat Oncol Biol Phys. 1996;  36 1205-1209
    CrossrefPubMedGoogle Scholar
  • 93 Öhrn K EO, Wahlin Y B, Sjöden P O. Oral status during radiotherapy and chemotherapy: a descriptive study of patient experiences and the occurrence of oral complications.  Supp Care Cancer. 2001;  9 247-257
    PubMedGoogle Scholar
  • 94 Mekhail T M, Adelstein D J, Rybicki L A, Larto M A, Saxton J P, Lavertu P. Enteral nutrition during the treatment of head and neck carcinoma.  Cancer. 2001;  91 1785-1790
    CrossrefPubMedGoogle Scholar
  • 95 Lees J. Nasogastric and percutaneous endoscopic gastrostomy feeding in head and neck cancer patients receiving radiotherapy treatment at a regional oncology unit: a two year study.  Eur J Cancer Care. 1997;  6 45-49
    CrossrefPubMedGoogle Scholar
  • 96 Roberge C, Tran M, Massoud C. et al . Quality of life and home enteral tube feeding: a French prospective study in patients with head and neck or oesophageal cancer.  Br J Cancer. 2000;  82 263-269
    CrossrefPubMedGoogle Scholar
  • 97 Weisdorf S A, Lysne J, Wind D. et al . Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation.  Transplantation. 1987;  43 833-838
    PubMedGoogle Scholar
  • 98 Herrmann V M, Petruska P J. Nutrition support in bone marrow transplant recipients.  Nutr Clin Pract. 1993;  8 19-27
    PubMedGoogle Scholar
  • 99 Szeluga D J, Stuart R K, Brookmeyer R, Utermohlen V, Santos G W. Nutritional support of bone marrow transplant recipients: a prospective, randomised clinical trial comparing total parenteral nutrition to an enteral feeding program.  Cancer Res. 1987;  47 3309-3316
    PubMedGoogle Scholar
  • 100 Roberts S R, Miller J E. Success using PEG tubes in marrow transplant recipients.  Nutr Clin Pract. 1998;  13 74-78
    PubMedGoogle Scholar
  • 101 Anderson P M, Ramsay N K, Shu X O. et al . Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation.  Bone Marrow Transplant. 1998;  22 339-344
    CrossrefPubMedGoogle Scholar
  • 102 Schloerb P R, Skikne B S. Oral and parenteral glutamine in bone marrow transplantation: a randomized, double-blind study.  JPEN. 1999;  23 117-122
    PubMedGoogle Scholar
  • 103 Coghlin-Dickson T M, Wong R M, Offrin R S. et al . Effect of oral glutamine supplementation during bone marrow transplantation.  JPEN. 2000;  24 61-66
    PubMedGoogle Scholar
  • 104 Bozzetti F. Is enteral nutrition a primary therapy in cancer patients?.  Gut. 1994;  35 S65-S68
    PubMedGoogle Scholar
  • 105 Rabeneck L, McCullough L B, Wray N P. Ethically justified, clinically comprehensive guidelines for percutaneous endoscopic gastrostomy tube placement.  Lancet. 1997;  349 496-498
    CrossrefPubMedGoogle Scholar
  • 106 Löser C, Müller M J. Ethische Richtlinien zur Anlage einer perkutan endoskopischen Gastrostomie (PEG-Sonde).  Zschr Gastroenterol. 1998;  36 475-478
    PubMedGoogle Scholar
  • 107 Bozzetti F. Effects of artificial nutrition on the nutritional status of cancer patients.  JPEN. 1989;  13 406-420
    PubMedGoogle Scholar
  • 108 Sartori S, Trevisani L, Tassinari D. et al . Cost analysis of long-term feeding by percutaneous endoscopic gastrostomy in cancer patients in an Italian health district.  Supp Care Cancer. 1996;  4 21-26
    PubMedGoogle Scholar
  • 109 Lindh A, Cedermark B, Blomgren H, Wassermann J, Petrini B. Enteral and parenteral nutrition in anorectic patients with advanced gastrointestinal cancer.  J Surg Oncol. 1986;  33 61-65
    PubMedGoogle Scholar

Dr. med. Jann Arends

Klinik für Tumorbiologie an der Albert-Ludwigs-Universität Freiburg

Breisacher Straße 117

79106 Freiburg

Email: arends@tumorbio.uni-freiburg.de